- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01658592
Deep Brain Stimulation of the Nucleus Accumbens and the Ventral Anterior Internal Capsule for Severe Alcohol Addiction
Deep Brain Stimulation of the Nucleus Accumbens and the Ventral Anterior Internal Capsule as a Novel Treatment in Severe Alcohol Addiction
The main objective of this study is to assess the efficacy of bilateral deep brain stimulation (DBS) of the nucleus accumbens (NAc) and the ventral anterior internal capsule (VC) as a novel treatment in severe alcohol addiction. The included patients have been treated so far with drugs that inhibits alcohol, or psychological behavior training.
Our hypothesis is that bilateral NAc-VC DBS will significantly reduce the craving for alcohol and thus enable the patients to decrease their alcohol intake substantially.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Study Type
Enrollment (Anticipated)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Shaanxi
-
Xi'an, Shaanxi, China, 710038
- Recruiting
- Department of Neurosurgery, Tangdu Hospital
-
Contact:
- Gao G Dong, Doctor
- Phone Number: +86 29-84777435
- Email: gguodong@fmmu.edu.cn
-
Contact:
- Wang X Lian, Doctor
- Phone Number: +86 29-84777284
- Email: tdwxlian@126.com
-
Sub-Investigator:
- Wang X Lian, Doctor
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Age > 18 years
- Long lasting alcohol addiction (fulfilled diagnostic-criteria according to DSM-IV,ICD-10)
- At least one detoxication-treatment without a long-term period of abstinence has already taken place
- Long-term inpatient treatment to support abstinence have occurred
- Free patient's decision / Informed Consent (existing comprehensive ability in meaning, methodology and execution of the study and ability of acceptance)
- If prior medication, stable dosage of psychopharmacological drugs over the last three months, which shall, after checking be retained during the study
Exclusion Criteria:
- Hospitalization for psychotic symptoms
- Clinical relevant psychiatric comorbidity (such as schizophrenic psychoses, bipolar affective diseases, severe personality disorder, and so on. And diagnosed by criteria according to DSM-IV,ICD-10)
- Contraindications of a MRI-examination, e.g. implanted cardiac pacemaker/ heart defibrillator
- Current and in the last six months existent paranoid-hallucinated symptomatology
- Foreign aggressiveness in the last six months
- Verbal IQ < 85 (evaluated with the Wechsler Adult Intelligence Scale- Chinese Revised (WAIS-CR)
- Stereotactic respectively neurosurgical intervention in the past
- Other neurological diseases
- Contraindications of a stereotactic operation, e.g. increased bleeding-disposition, cerebrovascular diseases (e.g. arteriovenous malfunction, aneurysms, systemic vascular diseases)
- Serious and instable organic diseases (e.g. instable coronal heart disease)
- tested positively for HIV
- pregnancy and/or lactation
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: Triple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: NAC-VC Deep Brain Stimulation
The contractors located in NAc and VC are ON at the same time
|
Stimulator setting is ON
Stimulator setting is OFF
|
|
Sham Comparator: Placebo A
Stimulator setting is OFF
|
Stimulator setting is ON
Stimulator setting is OFF
|
|
Experimental: Placebo B
The contractor located in NAc is on
|
Stimulator setting is ON
Stimulator setting is OFF
|
|
Experimental: Placebo C
The contactor located in VC is on
|
Stimulator setting is ON
Stimulator setting is OFF
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Reduction of Alcohol
Time Frame: 7 months
|
Reduction of the dosage of alcohol(all kinds of liquor were converted into pure alcohol) comparing baseline and the particular ward rounds during and at the end of the crossover-design.
|
7 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Craving
Time Frame: 7 months
|
10-point visual analog scale (VAS) of craving
|
7 months
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Psychological components
Time Frame: 7 months
|
Addiction severity(ASI); Psychological components (Anxiety (BAI-21 item); Depression (BDI-21 item); Quality of life (WHOQL-Brief); Health condition(SF-36).
|
7 months
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Gao G Dong, Doctor, Department of Neurosurgery, Tangdu Hospital
Study record dates
Study Major Dates
Study Start
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- NAc-VC DBS for alcohol addict
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Addiction
-
Gazi UniversityCompletedInternet Addiction | Game Addiction, VideoTurkey
-
Artvin Coruh UniversityRecruitingParenting | Social Media Addiction | Internet AddictionTurkey
-
Mersin UniversityÇankırı Karatekin University; Scientific and Technological Research Council...CompletedInternet Addiction | Smartphone Addiction | Technology AddictionTurkey (Türkiye)
-
Zagazig UniversityActive, not recruitingInternet Addiction | Gaming Disorder | Porn AddictionEgypt
-
Chengdu Sport UniversityNot yet recruitingInternet Addiction Disorder
-
The Hong Kong Polytechnic UniversityRecruiting
-
Cumhuriyet UniversityCompletedRisk Behavior | Social Media Addiction | Internet Addiction
-
Kafrelsheikh UniversityRecruiting
-
Karabuk UniversityCompleted
-
Kutahya Health Sciences UniversityCompleted
Clinical Trials on Deep brain stimulation
-
University of FloridaBoston Scientific CorporationRecruitingParkinson Disease | Deep Brain StimulationUnited States
-
Abbott Medical DevicesTerminatedDepressive Disorder, Major | Unipolar DepressionUnited States, Canada, United Kingdom
-
Ali Rezai, MDCompleted
-
Zhiqi MaoRecruitingParkinson's Disease | Executive Function | Electroencephalogram | Functional Near - Infrared SpectroscopyChina
-
University of CambridgeKing's College Hospital NHS Trust; Cambridge University Hospitals NHS Foundation...RecruitingAlcohol Use DisorderUnited Kingdom
-
University Hospital Inselspital, BerneCompletedMovement Disorder | Urinary Tract DiseaseSwitzerland
-
NewronikaTerminatedParkinson DiseaseItaly
-
University of California, San FranciscoNational Institute of Neurological Disorders and Stroke (NINDS)RecruitingPD - Parkinson's DiseaseUnited States
-
University of MinnesotaRecruitingParkinson DiseaseUnited States
-
Nova Scotia Health AuthorityNot yet recruitingParkinson DiseaseCanada